CA2177578A1 - Preventing and treating elevated intraocular pressure associated with administered or endogenous steroids using non-steroidal cyclooxygenase inhibitors - Google Patents

Preventing and treating elevated intraocular pressure associated with administered or endogenous steroids using non-steroidal cyclooxygenase inhibitors

Info

Publication number
CA2177578A1
CA2177578A1 CA002177578A CA2177578A CA2177578A1 CA 2177578 A1 CA2177578 A1 CA 2177578A1 CA 002177578 A CA002177578 A CA 002177578A CA 2177578 A CA2177578 A CA 2177578A CA 2177578 A1 CA2177578 A1 CA 2177578A1
Authority
CA
Canada
Prior art keywords
intraocular pressure
administered
preventing
pressure associated
elevated intraocular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002177578A
Other languages
French (fr)
Other versions
CA2177578C (en
Inventor
Jon R. Polansky
Ernest Bloom
Donald J. Fauss
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
Jon R. Polansky
Ernest Bloom
Donald J. Fauss
The Regents Of The University Of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/171,448 external-priority patent/US5474985A/en
Application filed by Jon R. Polansky, Ernest Bloom, Donald J. Fauss, The Regents Of The University Of California filed Critical Jon R. Polansky
Publication of CA2177578A1 publication Critical patent/CA2177578A1/en
Application granted granted Critical
Publication of CA2177578C publication Critical patent/CA2177578C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Methods and compositions for preventing or treating non-inflammatory elevated intraocular pressure associated with administered or endogenous steroids including administering to a mammalian organism a composition including (a) an ophthalmologically effective amount of non-steroidal cyclooxygenase inhibitor, and (b) a pharmaceutically acceptable carrier, to reduce or prevent an elevation of intraocular pressure and/or protein marker induction induced by chronic exposure to glucocorticoids.
CA002177578A 1993-12-22 1994-12-08 Preventing and treating elevated intraocular pressure associated with administered or endogenous steroids using non-steroidal cyclooxygenase inhibitors Expired - Fee Related CA2177578C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/171,448 US5474985A (en) 1993-12-22 1993-12-22 Preventing and treating elevated intraocular pressure associated with administered or endogenous steroids using non-steroidal cyclooxygenase inhibitors
US08/171,448 1993-12-22
PCT/US1994/014068 WO1995017178A1 (en) 1993-12-22 1994-12-08 Use of non-steroidal cyclooxygenase inhibitors to treat elevated intraocular pressure

Publications (2)

Publication Number Publication Date
CA2177578A1 true CA2177578A1 (en) 1995-06-29
CA2177578C CA2177578C (en) 2007-04-03

Family

ID=37951685

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002177578A Expired - Fee Related CA2177578C (en) 1993-12-22 1994-12-08 Preventing and treating elevated intraocular pressure associated with administered or endogenous steroids using non-steroidal cyclooxygenase inhibitors

Country Status (1)

Country Link
CA (1) CA2177578C (en)

Also Published As

Publication number Publication date
CA2177578C (en) 2007-04-03

Similar Documents

Publication Publication Date Title
MY113990A (en) Preventing and treating elevated intraocular pressure associated with administered or endogenous steroids using non-steroidal cyclooxygenase inhibitors
CA2173976A1 (en) Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
AU653415B2 (en) Method of treating ocular inflammation
TW350844B (en) Tricyclic amides useful to inhibition of G-protein function and for treatment of proliferative diseases
MY132056A (en) Methods of inhibiting physiological conditions associated with an excess of neuropeptide y.
WO2000027424B1 (en) Upregulation of endogenous prostaglandins to lower intraocular pressure
UA43391C2 (en) Method of cohesion inhibition and the method of inflammatory process inhibition and disrupted process of normal coagulation in patients with the disorders of the vascular endothelium
DE3172298D1 (en) Pharmaceutical compositions
AU4923093A (en) Inhibitors of metazoan parasite proteases
GT199700037A (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF RHINITIS
DE69720996D1 (en) NEW PHARMACEUTICAL COMPOSITIONS OF STEROID NITRATE ESTER FOR USE AS AN INFLAMMATORY INHIBITOR
ES2065846A1 (en) Pharmaceutical formulation based on a steroidal or non- steroidal anti-inflammatory agent and an antibiotic belonging to the DNA Girase inhibitors group for topical ophthalmic use
AU1345699A (en) Steroid 3-o-sulphamate derivatives as inhibitors of oestrone sulphatase
WO2000018353A3 (en) A novel inhibitor of cataract formation
WO1994005296A3 (en) Use of cytochrome p450 inhibitors for inhibiting the metabolism of nitrogen substituted acridine
TW325997B (en) Pharmaceutical composition for preventing and treating retinal diseases
CA2177578A1 (en) Preventing and treating elevated intraocular pressure associated with administered or endogenous steroids using non-steroidal cyclooxygenase inhibitors
AU7439996A (en) Novel uses of mammalian ctla-8 and related reagents
CA2061907A1 (en) Treatment of ocular hypertension with a synergistic combination
WO1990012577A3 (en) Topical anti-angiogenic as hair growth inhibitors
IE46171L (en) N-pyrrolidinylmethylbenzamide derivative.
AU557880B2 (en) Method for modulating the immune response with dibenzocycloheptenylidenes
AR005866A1 (en) ANTIOXIDANT PHARMACEUTICAL COMPOSITION
CA2090234A1 (en) Method for providing improved analgesic effect
EP0260790A3 (en) Use of pinacidil in the treatment of incontinence

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed